Nippon Chemiphar Co., Ltd.
JPX: 4539.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Kazushiro Yamaguchi
- Employees
- 887
- Headquarters
- Tokyo, Japan
- IPO year
- 2001
- Market cap
- ¥6B
- Website
- https://www.chemiphar.co.jp
Loading 4539…
Loading profile data…Frequently asked questions about 4539
What does Nippon Chemiphar Co., Ltd. (4539.T) do?
Nippon Chemiphar Co., Ltd., together with its subsidiaries, manufactures, markets, imports, exports, and sells, ethical pharmaceuticals and diagnostic agents in Japan and internationally. It offers diagnostic products, such as IgE NC, a diagnostic kit that provides results and reveals total IgE levels, as well as 57 individual allergen reagents;...
Where does 4539.T trade?
Nippon Chemiphar Co., Ltd. (4539.T) trades on the Tokyo Stock Exchange.
What sector is 4539.T in?
Nippon Chemiphar Co., Ltd. (4539.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Nippon Chemiphar Co., Ltd.?
Kazushiro Yamaguchi is the chief executive officer of Nippon Chemiphar Co., Ltd. (4539.T).
Where is Nippon Chemiphar Co., Ltd. headquartered?
Nippon Chemiphar Co., Ltd. is headquartered in Japan.
Does 4539.T pay a dividend?
Yes — Nippon Chemiphar Co., Ltd. (4539.T) paid a trailing twelve-month dividend of JPY 50.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4539.T go public?
Nippon Chemiphar Co., Ltd. (4539.T) completed its initial public offering in 2001.